Safe Prevention Clinics: A Missouri Solution to Harm Reduction
- Percy Menzies, M. Pharm.

- Apr 27
- 2 min read
We have seen a growing movement offering patient services under the umbrella of “harm reduction.” The number one goal is to keep patients alive in the hope that they will, at some point, seek treatment. The widespread distribution of the opioid-reversal medication naloxone has been very positive and should be continued.

The harm reduction movement has gone further by advocating for Safe Injection Facilities (SIFs), also called Safe Consumption Sites. Patients can come to these sites and inject their own drugs under the supervision of staff. In the event of an overdose, a staff member can quickly revive the individual. SIFs have appeared in several countries and cities and are highly controversial. Most communities are strongly opposed to such clinics in their neighborhoods. Sadly, harm reduction has become a form of de facto “treatment,” and there is now a strong backlash against this approach.
I agree with Susan Dalgety. In an era where we have failed to stem the flow of opioids and other drugs, I am proposing a radically different approach—Safe Prevention Clinics (SPCs). Community pharmacies have a unique opportunity to become SPCs. We have highly effective medications like naltrexone that take harm reduction to the next level—harm avoidance.
SPCs should be able to dispense naltrexone under a statewide standing prescription, as has been done with naloxone, for patients who are at higher risk of using opioids and those who want to control their alcohol consumption. SPCs can also provide information on treatment options and educational materials explaining what naltrexone is.
This approach would be free of controversy and welcomed by the community. Naltrexone is one of the few medications that has not been widely deployed as a public health measure to combat the opioid and alcohol epidemics, which have killed over a million people in the last 20 years.
If you or a loved one in Missouri is struggling with opioid use, Assisted Recovery Centers of America offers evidence-based treatment and support across the region.
If you would like to connect with Percy Menzies, M. Pharm., regarding this article, you can reach him through his LinkedIn profile

_edited.png)


The shift from simply handing out naloxone to pushing for Safe Injection Facilities is a big leap, and framing it as a “Missouri solution” is an interesting way to make it more palatable. I’ve been digging into the data on how these sites actually reduce public drug use, and I found a great breakdown on this at https://veo3-ai.pro
The point about naloxone being a clear win is one I fully agree with, but I also think the push for SIFs has gotten so polarizing that we're missing the middle ground. A pharmacy-based model for naltrexone makes a lot of sense to me since it meets people where they already are, without the stigma of a dedicated injection site. Speaking of testing things out, I actually ran a quick scroll test on my mouse the other day just to see if my wheel was acting up, and it got me thinking about how we need that same kind of hands-on, practical approach to harm reduction here.
The point about naloxone being a clear win is spot on, but framing SIFs as the logical next step feels like a stretch when Missouri’s real gap is treatment access, not just supervision. I’ve been digging into how clinics can bridge that gap with data-driven follow-up, and the resources at https://framepack-ai.com
Trump threatens 82 lottery new tariffs on European allies over Greenland until deal reached, as thousands protest...
Trump threatens 91 club new tariffs on European allies over Greenland until deal reached, as thousands protest..............................